AR098274A1 - Inhibidor de grelina o-acil transferasa - Google Patents

Inhibidor de grelina o-acil transferasa

Info

Publication number
AR098274A1
AR098274A1 ARP140104111A ARP140104111A AR098274A1 AR 098274 A1 AR098274 A1 AR 098274A1 AR P140104111 A ARP140104111 A AR P140104111A AR P140104111 A ARP140104111 A AR P140104111A AR 098274 A1 AR098274 A1 AR 098274A1
Authority
AR
Argentina
Prior art keywords
grelina
transferasa
acil
inhibitor
formula
Prior art date
Application number
ARP140104111A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR098274A1 publication Critical patent/AR098274A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reivindicación 1: Un compuesto caracterizado porque es de la fórmula (1) o una sal del mismo farmacéuticamente aceptable. Reivindicación 2: El compuesto caracterizado porque es de conformidad con la reivindicación 1 de la fórmula (2) o una sal del mismo farmacéuticamente aceptable.
ARP140104111A 2013-11-14 2014-11-03 Inhibidor de grelina o-acil transferasa AR098274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13382460 2013-11-14

Publications (1)

Publication Number Publication Date
AR098274A1 true AR098274A1 (es) 2016-05-18

Family

ID=49622771

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140104111A AR098274A1 (es) 2013-11-14 2014-11-03 Inhibidor de grelina o-acil transferasa

Country Status (40)

Country Link
US (1) US9035051B1 (es)
EP (1) EP3068775B1 (es)
JP (1) JP6159484B2 (es)
KR (1) KR101739243B1 (es)
CN (1) CN105636948B (es)
AP (1) AP2016009189A0 (es)
AR (1) AR098274A1 (es)
AU (1) AU2014348967B2 (es)
BR (1) BR112016009488B1 (es)
CA (1) CA2926224C (es)
CL (1) CL2016001023A1 (es)
CR (1) CR20160184A (es)
CY (1) CY1119489T1 (es)
DK (1) DK3068775T3 (es)
DO (1) DOP2016000070A (es)
EA (1) EA028550B1 (es)
ES (1) ES2647790T3 (es)
HK (1) HK1222860A1 (es)
HR (1) HRP20171648T1 (es)
HU (1) HUE035590T2 (es)
IL (1) IL244856A (es)
JO (1) JO3302B1 (es)
LT (1) LT3068775T (es)
MA (1) MA39025B1 (es)
ME (1) ME02841B (es)
MX (1) MX2016006223A (es)
NO (1) NO3068775T3 (es)
NZ (1) NZ718373A (es)
PE (1) PE20160609A1 (es)
PH (1) PH12016500895A1 (es)
PL (1) PL3068775T3 (es)
PT (1) PT3068775T (es)
RS (1) RS56533B1 (es)
SG (1) SG11201602953YA (es)
SI (1) SI3068775T1 (es)
TN (1) TN2016000145A1 (es)
TW (1) TWI538677B (es)
UA (1) UA118034C2 (es)
WO (1) WO2015073281A1 (es)
ZA (1) ZA201602202B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR104673A1 (es) * 2015-04-15 2017-08-09 Lilly Co Eli Inhibidores de grelina o-aciltransferasa
AR104672A1 (es) * 2015-04-15 2017-08-09 Lilly Co Eli Inhibidores de grelina o-aciltransferasa
ES2874587T3 (es) * 2016-08-05 2021-11-05 Boehringer Ingelheim Int Derivados de oxadiazolopiridina para su uso como inhibidores de la grelina O-aciltransferasa (GOAT)
CN106478519B (zh) * 2016-10-10 2018-12-11 上海再启生物技术有限公司 一种2-甲基-4-氨基-6-氯嘧啶的制备方法
US11136337B2 (en) 2018-02-02 2021-10-05 Boehringer Ingelheim International Gmbh Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
PE20210658A1 (es) 2018-02-02 2021-03-31 Boehringer Ingelheim Int Derivados de triazolopirimidina para usar como inhibidores de ghrelin o-aciltransferasa (goat)
CN111655699B (zh) * 2018-02-02 2023-07-14 勃林格殷格翰国际有限公司 用作饥饿素o-酰基转移酶(goat)抑制剂的杂环基取代的噁二唑并吡啶衍生物
JOP20200190A1 (ar) * 2018-02-02 2020-07-29 Boehringer Ingelheim Int مشتقات أوكسادايازولو بيريدين بها استبدال ببنزيل -، (بيريدين -3- يل) ميثيل - أو (بيريدين -4- يل) ميثيل كمثبطات جريلين o- أسيل ترانسفيراز (goat)
CN108558849A (zh) * 2018-05-30 2018-09-21 王丽萍 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用
CN108516971A (zh) * 2018-05-30 2018-09-11 王丽萍 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用
CN108774221A (zh) * 2018-05-30 2018-11-09 王丽萍 一种goat抑制剂及其在肥胖和糖尿病中的应用
CN108610337A (zh) * 2018-05-30 2018-10-02 王丽萍 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用
CN108558852A (zh) * 2018-05-30 2018-09-21 王丽萍 一种goat抑制剂及其在肥胖和糖尿病中的应用
JP2023526351A (ja) 2020-05-22 2023-06-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アルキル７－アミノ－５－メチル－［１，２，５］オキサジアゾロ［３，４－ｂ］ピリジンカルボキシレートの製造方法
EP4153600B1 (en) 2020-05-22 2024-08-07 Boehringer Ingelheim International GmbH Continuous process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458790B2 (en) * 2000-03-23 2002-10-01 Merck & Co., Inc. Substituted piperidines as melanocortin receptor agonists
US20060233788A1 (en) 2003-09-05 2006-10-19 Heiman Mark L Anti-ghrelin antibodies
WO2006019577A1 (en) 2004-07-14 2006-02-23 Eli Lilly And Company Anti-ghrelin antibodies
WO2006055347A2 (en) 2004-11-15 2006-05-26 Eli Lilly And Company Desacyl ghrelin antibodies and therapeutic uses thereof
US7525238B2 (en) 2005-01-26 2009-04-28 Kistler Holding Ag Ground insulated piezoelectric sensor for the measurement of acceleration or pressure
WO2006091381A1 (en) 2005-02-23 2006-08-31 Eli Lilly And Company Humanized anti-ghrelin antibodies
CA2608405A1 (en) * 2005-05-17 2006-11-23 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
CN101175759A (zh) * 2005-05-17 2008-05-07 先灵公司 作为治疗血脂异常的烟酸受体激动剂的杂环化合物
US20070213359A1 (en) * 2005-12-30 2007-09-13 Acadia Pharmaceuticals Inc. Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof
MX2010010241A (es) * 2008-03-20 2010-12-06 Forest Lab Holdings Ltd Derivados de piperidina novedosos como inhibidores de estearoil-coa desaturasa.
AR091516A1 (es) * 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida

Also Published As

Publication number Publication date
PH12016500895B1 (en) 2016-06-20
CY1119489T1 (el) 2018-03-07
DK3068775T3 (en) 2017-10-23
HUE035590T2 (en) 2018-05-28
ZA201602202B (en) 2019-10-30
DOP2016000070A (es) 2016-05-30
JO3302B1 (ar) 2018-09-16
PL3068775T3 (pl) 2018-01-31
KR20160068926A (ko) 2016-06-15
CL2016001023A1 (es) 2016-11-18
SI3068775T1 (sl) 2017-10-30
CA2926224A1 (en) 2015-05-21
JP2016537371A (ja) 2016-12-01
MX2016006223A (es) 2016-08-08
CR20160184A (es) 2016-06-17
US20150133474A1 (en) 2015-05-14
EP3068775B1 (en) 2017-09-06
RS56533B1 (sr) 2018-02-28
IL244856A0 (en) 2016-05-31
PT3068775T (pt) 2017-11-20
NO3068775T3 (es) 2018-02-03
TW201529073A (zh) 2015-08-01
CA2926224C (en) 2017-05-02
AU2014348967B2 (en) 2017-05-04
LT3068775T (lt) 2017-11-27
AU2014348967A1 (en) 2016-04-28
PH12016500895A1 (en) 2016-06-20
MA39025A1 (fr) 2017-05-31
CN105636948B (zh) 2017-10-24
IL244856A (en) 2017-07-31
KR101739243B1 (ko) 2017-05-23
HRP20171648T1 (hr) 2017-12-15
WO2015073281A1 (en) 2015-05-21
PE20160609A1 (es) 2016-07-03
SG11201602953YA (en) 2016-05-30
MA39025B1 (fr) 2018-05-31
ME02841B (me) 2018-01-20
BR112016009488B1 (pt) 2021-01-19
JP6159484B2 (ja) 2017-07-05
UA118034C2 (uk) 2018-11-12
US9035051B1 (en) 2015-05-19
EA201690764A1 (ru) 2016-07-29
TN2016000145A1 (en) 2017-10-06
ES2647790T3 (es) 2017-12-26
EA028550B1 (ru) 2017-11-30
BR112016009488A8 (pt) 2018-01-30
AP2016009189A0 (en) 2016-05-31
NZ718373A (en) 2017-12-22
CN105636948A (zh) 2016-06-01
HK1222860A1 (zh) 2017-07-14
EP3068775A1 (en) 2016-09-21
TWI538677B (zh) 2016-06-21

Similar Documents

Publication Publication Date Title
AR098274A1 (es) Inhibidor de grelina o-acil transferasa
AR110381A2 (es) Inhibidores biarilo de tirosina cinasa de bruton
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
AR094970A1 (es) Un inhibidor de mdm2 derivado de ácido benzoico para el tratamiento del cáncer
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
ECSP17010156A (es) Compuestos aminopirimidinilo como inhibidores jak
CR20150416A (es) Inhibidores de cdc7
CR20150507A (es) Inhibidores de histona desmetilasas
AR101995A1 (es) COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6
AR095039A1 (es) Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico
ECSP17054980A (es) Inhibidores selectivos de bace1
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
AR095097A1 (es) Compuestos de fenoxietoxi
SV2017005418A (es) Inhibidor de cinasa aurora a
EA201592268A1 (ru) Дигидропиридиноновые ингибиторы mgat2
AR105967A1 (es) Sales de un inhibidor de pim quinasa
AR105821A1 (es) COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T
EA201591915A1 (ru) Соединения феноксиэтил дигидро-1h-изохинолина
CO2019005165A2 (es) Compuesto de piridona como inhibidor de c-met
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
JO3742B1 (ar) مركب بيرانو داي بيريدين
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
ES2571452T3 (es) Compuesto antagonista de leucotrieno B4
CY1119540T1 (el) Υποκατασταθεντα απο γλυκοπυρανοσυλιο παραγωγα ινδολο-ουριας και η χρηση τους ως αναστολεις sglt
AR107163A1 (es) Inhibidores de quinasa

Legal Events

Date Code Title Description
FB Suspension of granting procedure